首页 | 本学科首页   官方微博 | 高级检索  
     


Long‐term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5­year observational study (ENTRUST)
Authors:Elliott Vichinsky  Amal El‐Beshlawy  Azzam Al Zoebie  Annie Kamdem  Suzanne Koussa  Thirachit Chotsampancharoen  Andreas Bruederle  Geralyn Gilotti  Jackie Han  Mohsen Elalfy
Affiliation:1. UCSF Benioff Children's Hospital & Research Center Oakland, Oakland, California;2. Cairo University, Cairo, Egypt;3. Sheikh Khalifa Medical City, Abu Dhabi, UAE;4. Centre Hospitalier Intercommunal, Créteil, France;5. Chronic Care Center, Hazmieh, Lebanon;6. Songklanagarind Hospital, Songkhla, Thailand;7. Novartis Pharma AG, Basel, Switzerland;8. Novartis Pharmaceuticals, East Hanover, New Jersey;9. Ain Shams University, Cairo, Egypt
Abstract:
Keywords:deferasirox  hemosiderosis  iron chelation  iron overload  pediatric  real world
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号